Researchers at Harvard Medical School have repurposed anthrax, a bacterial toxin known for its lethal effects, into a potent pain blocker that could someday…
People of color in the U.S. and UK were up to three times likelier than white people to report being unsure or unwilling to…
The SARS-CoV-2 Omicron variant’s “milder” outcomes are likely due to more population immunity rather than the virus’ properties, according to a paper by William…
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs) — a…
For the past two months your mood has been low, you’ve lost your appetite, and you can’t sleep well. Your family is concerned because…
A recent letter published in the journal Science aims to jump-start conversations on the importance of inclusive language in the sciences as part of…
Some physicians are far more likely to deliver appropriate care than others in the same geographic area or health care system, according to a…
As weary Americans hold out hope that the decline of Omicron signals an end to the pandemic’s emergency phase, physicians who treat long COVID…
As more governors end mask mandates, and as Omicron fades and a range of new anti-COVID tools emerge, risk-reduction experts say that now is…